Loading…
Loading…
Custom Health Holdings Inc (TSX:CHLT) just landed Buy-rated coverage from Stifel, with analysts setting a C$12 price target and pointing to upside as high as C$18 a share. The pitch: a pill-dispensing platform that's quietly solving one of healthcare's most expensive headaches.
Ron Kruszewski, Stifel chairman and ceo, says artificial intelligence will lead to productivity gains. He says financial advisers are still valuable and AI can help them.
Stifel Financial Corp. (SF) Q2 2026 Earnings Call Transcript
Stifel Financial NYSE: SF reported what executives described as the strongest first half in the company's history, with second-quarter revenue and earnings rising from a year earlier as wealth management, investment banking and net interest income all contributed to growth.
Stifel Financial remains a "Buy" despite recent underperformance, with AI-driven cash sweep fears seen as overdone and not reflected in current results. Q2 earnings beat expectations, with revenue up 11% to $1.45 billion and client assets rising 12% to $580 billion, supporting robust wealth management and investment banking momentum. Net interest income, a key profit driver, remains resilient; cash balances are stable, and Fed rate hikes could further benefit SF's earnings.
Stifel Financial (SF) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.35 per share. This compares to earnings of $1.14 per share a year ago.
ST. LOUIS, July 22, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.45 billion for the three months ended June 30, 2026, compared with $1.28 billion a year ago. Net income available to common shareholders was $217.2 million, or $1.34 per diluted common share, compared with $145.7 million, or $0.89 per diluted common share (1) for the second quarter of 2025.
STAMFORD, Conn. , July 20, 2026 (GLOBE NEWSWIRE) -- Eaton Partners, one of the largest private capital advisory firms and a wholly-owned subsidiary of Stifel Financial Corp. (NYSE: SF), is announcing key appointments to expand its Private Capital Advisory ("PCA") group, including the addition of Mickey Brunton as Managing Director and Co-Head of GP-led Secondaries.
SEC filings for SF aren't indexed yet — common for recently launched funds. Browse the issuer's filings on SEC EDGAR directly.